LexOrbis
Facebook Twitter LinkedIn

Menu

  • Home
  • About Us
    • Who we are
    • Our People
    • Our Reach
  • Practice
    • Patents
    • Designs
    • Trademarks
    • Copyright
  • Global IP Solutions
    • Patent Search & Analytics
      • Knock-out Search
      • Patentability Search
      • Freedom to Operate
      • Invalidity Search
      • Infringement Search
      • Competitor Watch
      • Landscape / White Space Analysis
    • Patent Drafting
    • Global Patent Filing & Prosecution
      • Pre-Filing Review
      • Patent Drawings
      • Application Preparation and E-filing
      • Office Action Response
      • IDS Management
      • Post Allowance Review
      • Patent Proofreading
      • PTA Calculation
      • Paralegal Support
    • Trademark Search & Watch
      • Trademark Comprehensive Search
      • Trademark Watch
      • Counterfeit Watch
      • Domain Name Watch
    • Global Trademark Filing & Prosecution
      • Pre-Filing Review
      • Application Preparation and E-filing
      • Examination Report Response
      • Paralegal Support
    • IP Portfolio Management
      • IP Docketing
      • Data Validation
      • Invoice Management and Spend Analysis
      • IP Recordals
      • Patent Annuities
      • Trademark Renewals and Restoration
      • Special Projects
  • Updates
  • Events
  • Recognitions
  • Careers
  • Contact

Patent

78% Of The Patent Filings In India By Non-Residents

November 14, 2014September 23, 2016 LexOrbis Patent

Non-residents filed 78.3 per cent of the total number of patent applications in India in the year 2012, as per the latest data […]

Important Ruling on Section 8 of the Patents Act, 1970

November 8, 2014September 23, 2016 LexOrbis Patent

A notable ruling has come from Delhi High Court on revocation of patents. Section 8 of the India Patents Act, 1970 (the “Act”) […]

Guidelines for examination of patent applications inthe field of pharmaceuticals launched by CGPDTM

October 31, 2014September 23, 2016 LexOrbis Patent

Controller General of Patents, Designs & Trade Marks launched “Guidelines for examination of patent applications in the field of Pharmaceuticals” after extensive consultation […]

Cipla asks government to cancel Novartis patents onrespiratory drug

October 31, 2014September 23, 2016 LexOrbis Patent

Indian generic drug maker Cipla Ltd. has requested the Indian government to revoke five patents held by Swiss Firm Novartis AG on respiratory […]

Indian government constituted a thinktank to draft a national IPR policy

October 31, 2014September 23, 2016 LexOrbis Patent

Indian government constituted a thinktank to draft a national IPR policy The Department of Industrial Policy and Promotion in the Ministry of Industry […]

Post navigation

Newer posts →

News & Updates

  • News (115)
  • Copyright (131)
  • Patent (515)
  • Trademark (486)
  • Others (653)
    • Events (69)
  • Recognitions (126)
  • Designs (4)

Recent Posts

  • Refusal of Pharmaceutical Combination Patent Application Set Aside by Delhi High Court August 18, 2026
  • Pet Appetite and Weight-Loss Drug Survives Patent Rejection: Madras High Court Finds Refusal Order Arbitrary August 18, 2026
  • Analysing the MSME Development (Amendment) Bill, 2026: Proposed Changes to Registration, Delayed Payments and Dispute Resolution August 18, 2026
  • Gujarat High Court Sets Aside Interim Injunction Due to Erred Assessment of Evidence August 18, 2026
  • CDSCO Issues Guidance on Medical Device Software under the Medical Devices Rules, 2017 August 13, 2026

Archives

Subscribe

Name

Email


© 2026 - Lexorbis. All Rights Reserved.   Privacy Policy  |  Terms of Use

This website follows the relevant rules of the Bar Council of India. By clicking, “I Agree” below, the user acknowledges and confirms that the contents of website are meant to provide necessary information about the firm, LexOrbis and updates on relevant laws in India. The information provided herein is not legal advice, and the Firm disclaims all liability arising from reliance placed by the user on the information contained therein. The Firm has made all efforts to ensure the accuracy of the contents of this website. The user also confirms that there has been no advertisement, personal communication, solicitation, invitation or inducement of any sort whatsoever from the Firm or any of its members to solicit any work or advertise through this website.

Please read and accept this Website’s Terms of Use and Privacy Policy before accessing the same.

I Agree I Disagree